236 related articles for article (PubMed ID: 28078405)
1. [Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma].
Hamm K; Herold HU; Surber G; Rosahl S
HNO; 2017 May; 65(5):434-442. PubMed ID: 28078405
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution.
Andrews DW; Suarez O; Goldman HW; Downes MB; Bednarz G; Corn BW; Werner-Wasik M; Rosenstock J; Curran WJ
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1265-78. PubMed ID: 11483338
[TBL] [Abstract][Full Text] [Related]
3. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.
Kessel KA; Fischer H; Vogel MM; Oechsner M; Bier H; Meyer B; Combs SE
Strahlenther Onkol; 2017 Mar; 193(3):192-199. PubMed ID: 27803960
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
[TBL] [Abstract][Full Text] [Related]
5. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.
Germano IM; Sheehan J; Parish J; Atkins T; Asher A; Hadjipanayis CG; Burri SH; Green S; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E49-E51. PubMed ID: 29309637
[TBL] [Abstract][Full Text] [Related]
6. Effects of CyberKnife therapy for vestibular schwannoma on hearing: a retrospective study.
Çakır O; Berkiten G; Tutar B; Yılmazer AB; Kumral TL; Saltürk Z; Uyar Y
J Laryngol Otol; 2018 Sep; 132(9):796-801. PubMed ID: 30180915
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy in three weekly fractions for the management of vestibular schwannomas.
Gallogly JA; Jumaily M; Faraji F; Mikulec AA
Am J Otolaryngol; 2018; 39(5):561-566. PubMed ID: 29961654
[TBL] [Abstract][Full Text] [Related]
8. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
9. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
10. Is hearing preserved following radiotherapy for vestibular schwannoma?
Coughlin AR; Hunt AA; Gubbels SP
Laryngoscope; 2019 Apr; 129(4):775-776. PubMed ID: 30284268
[No Abstract] [Full Text] [Related]
11. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
12. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
13. Adaptive hybrid surgery analysis (AHSA) for adjuvant gamma knife radiosurgery treatment of vestibular schwannoma residuals.
Bartek J; Wangerid T; Pettersson-Segerlind J; Benmakhlouf H; Förander P
Clin Neurol Neurosurg; 2019 Oct; 185():105487. PubMed ID: 31476593
[TBL] [Abstract][Full Text] [Related]
14. Radiation for Sporadic Vestibular Schwannoma: An Update on Modalities, Emphasizing Hearing Loss, Side Effects, and Tumor Control.
Woodson E
Otolaryngol Clin North Am; 2023 Jun; 56(3):521-531. PubMed ID: 37019768
[TBL] [Abstract][Full Text] [Related]
15. Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis.
Nguyen T; Duong C; Sheppard JP; Lee SJ; Kishan AU; Lee P; Tenn S; Chin R; Kaprealian TB; Yang I
Clin Neurol Neurosurg; 2018 Mar; 166():116-123. PubMed ID: 29414150
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
17. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
18. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.
Meijer OW; Vandertop WP; Baayen JC; Slotman BJ
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1390-6. PubMed ID: 12873685
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiotherapy for vestibular schwannoma.
Sweeney P; Yajnik S; Hartsell W; Bovis G; Venkatesan J
Otolaryngol Clin North Am; 2009 Aug; 42(4):655-63. PubMed ID: 19751870
[TBL] [Abstract][Full Text] [Related]
20. Cyberknife radiotherapy for vestibular schwannoma.
Sakamoto GT; Blevins N; Gibbs IC
Otolaryngol Clin North Am; 2009 Aug; 42(4):665-75. PubMed ID: 19751871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
